FDA says as of Oct 14, 2025, J&J Medtech (JNJ) has reported four serious injuries and one death associated with detachable coil system issue

FDA says as of Oct 14, 2025, J&J Medtech (JNJ) has reported four serious injuries and one death associated with detachable coil system issue.

The FDA's announcement regarding serious injuries and one death linked to Johnson & Johnson's detachable coil system raises significant concerns about product safety and regulatory scrutiny. For J&J, this could potentially impact their reputation and sales trajectory, as ongoing safety issues may affect investor sentiment and stock performance. Traders should monitor for any further developments, potential recalls, or legal ramifications that might arise from this report.